Anti Biofilm Wound Dressing Market to Reach Valuation of USD 1315.59 Million by 2030 – Growth in the Adoption of Cloud and Big Data Drives the Market

In terms of revenue, the Global Anti Biofilm Wound Dressing Market is expected to reach USD 1315.59 Million by 2030, growing at a CAGR (Compound Annual Growth Rate) of 9.2% from 2023 to 2030.

The increase in the incidents of chronic diseases such as diabetes, cancer, and other autoimmune disorders is anticipated to increase the incidence rate of chronic and acute wounds across the globe. An increase in chronic diseases results in prolonged hospitalization and surgeries, which can increase the demand for the Anti Biofilm Wound Dressing market. Several other factors like the development of healthcare infrastructure across developing countries, technological advancements in the management of wounds and efforts that healthcare providers and key market players take to increase the awareness of wound care. By providing low-risk procedures in a convenient setting, Ambulatory Surgical Centers (ASCs) are revolutionizing healthcare delivery by offering lower costs than hospitals are becoming more popular. Furthermore, the cases of diabetic foot ulcers in a lifetime increased from 19% to 34%. Since anti-biofilm dressings are highly recommended for treating chronic wounds, the market is expected to grow more.

Key Highlights from the Report

· Based on the Mode of Mechanism, the chemical mode of mechanism segment is anticipated to dominate the Anti Biofilm Wound Dressing market with the largest market share in the forecast period considering the growing number of surgeries worldwide.

· Based on Wound Type, the acute wounds segment accounted for the maximum CAGR during the forecast period due to the increasing number of trauma cases worldwide

· In terms of Region, North America held the major market share in 2022 and is likely to be the most gainful market in the future. increasing use of advanced products in healthcare facilities such as hospitals and ambulatory surgery centers in the United States are aiding this market expansion.

Market Dynamics

The increase in the incidents of chronic diseases such as diabetes, cancer, and other autoimmune disorders is anticipated to increase the incidence rate of chronic and acute wounds across the globe. Factors such as antimicrobial resistance, unhealthy & sedentary lifestyles, and tobacco & alcohol consumption are contributing to the rising prevalence of non-communicable diseases. For example, in its report, World Health Organization says that every one in six people is killed due to cancer yearly, with more than 70 per cent of cancer-related deaths occurring in countries with low or middle-income groups. An increase in chronic diseases results in prolonged hospitalization and surgeries, which can increase the demand for the Anti Biofilm Wound Dressing market.

Several other factors like the development of healthcare infrastructure across developing countries, technological advancements in the management of wounds and efforts that healthcare providers and key market players take to increase the awareness of wound care. By providing low-risk procedures in a convenient setting, Ambulatory Surgical Centers (ASCs) are revolutionizing healthcare delivery by offering lower costs than hospitals are becoming more popular. According to the studies by B Braun Melsungen AG in 2018 incidence of diabetic foot ulcers in people with diabetes ranges from 2% to 10%. Furthermore, the cases of diabetic foot ulcers in a lifetime increased from 19% to 34%. Since anti-biofilm dressings are highly recommended for treating chronic wounds, the market is expected to grow more.

However, the high cost of wound care coupled with a shortage of skilled physicians is expected to limit market growth. Nevertheless, the increasing number of patients suffering from acute wounds is anticipated to remove the issue of costly treatment.

North America Anti Biofilm Wound Dressing market is expected to witness a noteworthy development with a significant growth rate over the analysis period. Notable industry participants like ConvaTec Inc., Smith & Nephew PLC, Urgo Medical, and Coloplast are anticipated to accelerate market growth in the area. Additionally, one of the main drivers behind the growth of the North America market studied is the increasing use of advanced products in healthcare facilities such as hospitals and ambulatory surgery centers in the United States. The presence of key market players such as 3M, B. Braun SE, Convatec Inc., Smith & Nephew and Coloplast Corp in the region and a favorable cost recovery policy should boost the market. Also, according to various studies conducted, around 100 million patients require wound care every year, which is expected to drive the market in China. Apart from these, Europe is expected to record a CAGR of 9.1% as wounds are a growing concern in Europe, and their treatment involves a variety of resources. This expected increase in the Anti Biofilm Wound Dressing market is due to the ageing population and increased prevalence of long-term chronic conditions.

The Global Anti Biofilm Wound Dressing Market is Segmented as follows

• Mode of Mechanism
  • Physical
  • Chemical
  • Biological
• Wound Type
  • Chronic Wounds
  • Acute Wounds
• End-Use
  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Other End-Uses
• Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

List of the Key Players of the Global Anti Biofilm Wound Dressing Market is

ConvaTec Inc. (UK), Smith & Nephew PLC (UK), Urgo Medical (U.S.), Coloplast (India), 3M (U.S.), Mölnlycke Health Care AB (Sweden), Imbed Biosciences (U.S.), Next Science (Australia), B. Braun Melsungen AG (Germany), Lohmann & Rauscher (Germany)

The Global Anti Biofilm Wound Dressing Market Scope can be Tabulated as below